Results 271 to 280 of about 1,463,285 (410)
The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes. [PDF]
Norberto Perico+3 more
openalex +1 more source
The Reconstruction of Peripheral Auditory Circuit: Recent Advances and Future Challenges
This paper summarizes the potential of biomaterials, stem cells, and gene editing technologies in the regeneration of inner ear hair cells, spiral ganglion neurons, and inner ear organoids. Challenges and potential developments are discussed and explored.
Zhe Li+3 more
wiley +1 more source
Kidney Disease and Hematopoietic Stem Cell Transplantation. [PDF]
Renaghan AD, Costa JM, Esteves A.
europepmc +1 more source
This study verifies that circRNA‐mTOR exhibits high expression levels in HCC and has a strong correlation with patient prognosis. Mechanistically, circRNA‐mTOR achieves this effect by facilitating the nuclear translocation of RNA‐binding protein (RBP) PSIP1 through specific binding.
Yongchang Tang+12 more
wiley +1 more source
Editorial: Improving stem cell transplantation delivery using computational modelling. [PDF]
Raghav PK.
europepmc +1 more source
Blood stem cell transplantation: From preclinical to clinical models [PDF]
Theodor M. Fliedner
openalex +1 more source
XLP mitigated CPT11 mucositis by suppressing GUS‐expressing microbes, notably L. reuteri, and diminishing bacterial GUS activity, consequently reducing SN38 accumulation to protect the intestinal epithelium. This preservation of the mucosal stem cell niche enabled rapid regeneration of secretory lineages such as mucin‐producing goblet cells, which ...
Bei Yue+15 more
wiley +1 more source
Prospective Evaluation of Cardiorespiratory Fitness After Hematopoietic Stem Cell Transplantation in Children. [PDF]
Houdouin V+7 more
europepmc +1 more source
High‐Dose Chemotherapy with Peripheral Blood Stem‐Cell Transplantation for Hormone‐Refractory Advanced Carcinoma of the Prostate: Experience of Two Cases [PDF]
Tsutomu Nishiyama+4 more
openalex +1 more source
αPD‐1 therapy has left an indelible mark in the field of NSCLC treatment; however, its efficacy is limited in clinical practice owing to the effector T‐cell exhaustion. These findings underscore CK2B as a promising target for overcoming the exhaustion of effector CD8+ T cells, thereby enhancing the efficacy of αPD‐1 and adoptive cell therapies in NSCLC.
Shaochuan Liu+15 more
wiley +1 more source